# An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma

> **NCT04607629** · PHASE3 · COMPLETED · sponsor: **AO GENERIUM** · enrollment: 192 (actual)

## Conditions studied

- Bronchial Asthma

## Interventions

- **BIOLOGICAL:** Genolar® + Symbicort®
- **BIOLOGICAL:** Xolair® + Symbicort®

## Key facts

- **NCT ID:** NCT04607629
- **Lead sponsor:** AO GENERIUM
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-20
- **Primary completion:** 2019-04-29
- **Final completion:** 2019-12-13
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2020-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04607629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04607629, "An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04607629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*